CFTR and cystic fibrosis: A recently tested LNP (MRT-5005) demonstrated a 1500-fold increase of transgene expression over endogenous CFTR in preclinical species, rescue of CF human airway epithelial cells with an optimized CFTR mRNA, and an ability to be redosed resulting in sustained expression, an essential requirement for a transient mRNA gene therapy.